top of page

Search
![[Volume 28. Neural Concept: AI-First 3D Deep Learning Platform Transforming Engineering Design vs Traditional CAD/CAE Tools]](https://static.wixstatic.com/media/de513c_620f22753b674c7abc1da52e8d0745c2~mv2.png/v1/fill/w_333,h_250,fp_0.50_0.50,lg_1,q_35,blur_30,enc_avif,quality_auto/de513c_620f22753b674c7abc1da52e8d0745c2~mv2.webp)
![[Volume 28. Neural Concept: AI-First 3D Deep Learning Platform Transforming Engineering Design vs Traditional CAD/CAE Tools]](https://static.wixstatic.com/media/de513c_620f22753b674c7abc1da52e8d0745c2~mv2.png/v1/fill/w_325,h_244,fp_0.50_0.50,q_95,enc_avif,quality_auto/de513c_620f22753b674c7abc1da52e8d0745c2~mv2.webp)
[Volume 28. Neural Concept: AI-First 3D Deep Learning Platform Transforming Engineering Design vs Traditional CAD/CAE Tools]
Neural Concept: Real-Time Physics Simulation Platform with AI-Based Engineering Intelligence Executive Overview Founded: 2018 (EPFL spinoff) Headquarters: Lausanne, Switzerland (EPFL Innovation Park) Website: https://www.neuralconcept.com Status: Private Company Core Service: 3D Deep Learning-based Engineering Intelligence Platform Total Funding: $38M across 3 rounds Seed: $2M (2020) Series A: $9.1M (March 2022, led by Alven) Series B: $27M (June 2024, led by Forestay Capital
14 minutes ago
[LLM-based Platform for Automated Protein Structure Analysis and Drug Development-Poster presented at the 2025 Autumn Conference of the Korean Society of Medical and Biological Engineering]
Introduction Challenge in Drug Development: Protein structure preprocessing is a critical step that determines the accuracy of molecular docking and molecular dynamics simulations Experimental structures (X-ray, NMR) contain unnecessary water molecules, crystallization ligands, metal ions, and incomplete hydrogen information Differences from physiological environments reduce reliability for computational studies Limitations of Current Preprocessing: Requires sequential use of
Nov 6
[The Journal of the Korea Society for Naval Science & Technology: Real-time Threat Analysis and Decision Support System for the Korean Peninsula Based on Multi-AI Model Fusion]
My research paper "Real-time Threat Analysis and Decision Support System for the Korean Peninsula Based on Multi-AI Model Fusion" has been published in the Journal of the Korea Society for Naval Science & Technology on September 30th. As a Navy reservist, it is deeply meaningful to contribute, even in a small way, to the ROK Navy and national defense. I have invested nearly a year in planning and developing TARGIS BUSAN, continuing to advance it even on holidays and weekends
Oct 19
![[Volume 27. TraceLink: Digital Network Platform for Pharmaceutical Supply Chain Orchestration vs Traditional Supply Chain Management]](https://static.wixstatic.com/media/de513c_9571203549694e85aba274121a788a84~mv2.png/v1/fill/w_333,h_250,fp_0.50_0.50,lg_1,q_35,blur_30,enc_avif,quality_auto/de513c_9571203549694e85aba274121a788a84~mv2.webp)
![[Volume 27. TraceLink: Digital Network Platform for Pharmaceutical Supply Chain Orchestration vs Traditional Supply Chain Management]](https://static.wixstatic.com/media/de513c_9571203549694e85aba274121a788a84~mv2.png/v1/fill/w_325,h_244,fp_0.50_0.50,q_95,enc_avif,quality_auto/de513c_9571203549694e85aba274121a788a84~mv2.webp)
[Volume 27. TraceLink: Digital Network Platform for Pharmaceutical Supply Chain Orchestration vs Traditional Supply Chain Management]
TraceLink : End-to-End Operations With Real-Time Data for Optimal Business Outcomes Executive Overview Founded: 2009 (originally as SupplyScape in 2003) Headquarters: Wilmington, Massachusetts, USA (previously North Reading, MA) Website: https://www.tracelink.com Status: Private Company Core Service: Digital network platform for end-to-end pharmaceutical supply chain orchestration Total Funding: $230M across 8 rounds Annual Revenue: Estimated $200M+ (2024) Leadership:
Oct 14
![[Volume 26. Codexis: AI-Powered Enzyme Engineering vs Traditional Chemical Manufacturing]](https://static.wixstatic.com/media/de513c_2244a0e40a844921899414bfc2647bdf~mv2.png/v1/fill/w_333,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/de513c_2244a0e40a844921899414bfc2647bdf~mv2.webp)
![[Volume 26. Codexis: AI-Powered Enzyme Engineering vs Traditional Chemical Manufacturing]](https://static.wixstatic.com/media/de513c_2244a0e40a844921899414bfc2647bdf~mv2.png/v1/fill/w_325,h_244,fp_0.50_0.50,q_95,enc_avif,quality_auto/de513c_2244a0e40a844921899414bfc2647bdf~mv2.webp)
[Volume 26. Codexis: AI-Powered Enzyme Engineering vs Traditional Chemical Manufacturing]
CODEXIS CodeEvolver Executive Overview Founded: 2002 Headquarters: Redwood City, California, USA Website: https://www.codexis.com...
Oct 11
![[Volume 25. Insilico Medicine: Where Biology Meets Generative Intelligence]](https://static.wixstatic.com/media/de513c_fdee5f8796094c0db745d7dd62f05d62~mv2.jpg/v1/fill/w_333,h_250,fp_0.50_0.50,q_30,blur_30,enc_avif,quality_auto/de513c_fdee5f8796094c0db745d7dd62f05d62~mv2.webp)
![[Volume 25. Insilico Medicine: Where Biology Meets Generative Intelligence]](https://static.wixstatic.com/media/de513c_fdee5f8796094c0db745d7dd62f05d62~mv2.jpg/v1/fill/w_325,h_244,fp_0.50_0.50,q_90,enc_avif,quality_auto/de513c_fdee5f8796094c0db745d7dd62f05d62~mv2.webp)
[Volume 25. Insilico Medicine: Where Biology Meets Generative Intelligence]
Executive Overview Insilico Pharma.Ai Founded: 2014 Headquarters: Cambridge, Massachusetts, USA Globla Locations: Hong Kong (R&D Hub),...
Oct 9
bottom of page


